Mapping and analysis of chromatin state dynamics in nine human cell types. by Ernst, Jason et al.
UCLA
UCLA Previously Published Works
Title
Mapping and analysis of chromatin state dynamics in nine human cell types.
Permalink
https://escholarship.org/uc/item/47r1n67b
Journal
Nature, 473(7345)
ISSN
0028-0836
Authors
Ernst, Jason
Kheradpour, Pouya
Mikkelsen, Tarjei S
et al.
Publication Date
2011-05-01
DOI
10.1038/nature09906
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
Systematic analysis of chromatin state dynamics in nine human 
cell types
Jason Ernst1,2, Pouya Kheradpour1,2, Tarjei S. Mikkelsen1, Noam Shoresh1, Lucas D. 
Ward1,2, Charles B. Epstein1, Xiaolan Zhang1, Li Wang1, Robbyn Issner1, Michael Coyne1, 
Manching Ku1,3,4, Timothy Durham1, Manolis Kellis1,2,*, and Bradley E. Bernstein1,3,4
1Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA
2MIT Computer Science and Artificial Intelligence Laboratory, Cambridge, Massachusetts, USA
3Howard Hughes Medical Institute, Department of Pathology, Massachusetts General Hospital 
and Harvard Medical School, Boston, Massachusetts, USA
4Center for Systems Biology and Center for Cancer Research, Massachusetts General Hospital, 
Boston, Massachusetts, USA
Abstract
Chromatin profiling has emerged as a powerful means for genome annotation and detection of 
regulatory activity. Here we map nine chromatin marks across nine cell types to systematically 
characterize regulatory elements, their cell type-specificities, and their functional interactions. 
Focusing on cell type-specific patterns of promoters and enhancers, we define multi-cell activity 
profiles for chromatin state, gene expression, regulatory motif enrichment, and regulator 
expression. We use correlations between these profiles to link enhancers to putative target genes, 
and predict the cell type-specific activators and repressors that modulate them. The resulting 
annotations and regulatory predictions have implications for interpreting genome-wide association 
studies. Top-scoring disease SNPs are frequently positioned within enhancer elements specifically 
active in relevant cell types, and in some cases affect a motif instance for a predicted regulator, 
thus proposing a mechanism for the association. Our study presents a general framework for 
deciphering cis-regulatory connections and their roles in disease.
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Introduction
A major challenge in biology is to understand how a single genome can give rise to an 
organism comprising hundreds of distinct cell types. Much emphasis has been placed on the 
application of high-throughput tools to study interacting cellular components1. The field of 
systems biology has exploited dynamic gene expression patterns to reveal functional 
modules, pathways and networks2. Yet cis-regulatory elements, which may be equally 
dynamic, remain largely uncharted across cellular conditions.
Chromatin profiling provides a systematic means for detecting cis-regulatory elements, 
given the central role of chromatin in mediating regulatory signals and controlling DNA 
access, and the paucity of recognizable sequence signals. Specific histone modifications 
correlate with regulator binding, transcriptional initiation and elongation, enhancer activity 
and repression1,3-6. Combinations of modifications can provide even more precise insight 
into chromatin state7,8.
Here, we apply a high-throughput pipeline to map 9 chromatin marks and input controls 
across 9 cell types. We use recurrent combinations of marks to define 15 chromatin states 
corresponding to repressed, poised, and active promoters, strong and weak enhancers, 
putative insulators, transcribed regions, and large-scale repressed and inactive domains. We 
use directed experiments to validate biochemical and functional distinctions between states.
The resulting chromatin state maps portray a highly dynamic landscape, with the specific 
patterns of change across cell types revealing strong correlations between interacting 
functional elements. We use correlated patterns of activity between chromatin state, gene 
expression and regulator activity to connect enhancers to likely target genes, to predict cell 
type-specific activators and repressors, and to identify individual binding motifs responsible 
for these interactions.
Our results have implications for interpreting genome-wide association studies. We find that 
disease variants frequently coincide with enhancer elements specific to a relevant cell type. 
In several cases, we can predict upstream regulators whose regulatory motif instances are 
affected or target genes whose expression may be altered, thereby proposing specific 
mechanistic hypotheses for how disease-associated genotypes lead to the observed disease 
phenotypes.
Results
Systematic mapping of chromatin marks in multiple cell types
To explore chromatin state in a uniform way across multiple cell types, we applied a 
production pipeline for chromatin immunoprecipitation followed by high-throughput 
sequencing (ChIP-seq) to generate genome-wide chromatin datasets (see Methods, Fig. 1a). 
We profiled nine human cell types, including common lines designated by the ENCODE 
consortium1 and primary cell types. These consist of embryonic stem cells (H1 ES), 
erythrocytic leukemia cells (K562), B-lymphoblastoid cells (GM12878), hepatocellular 
carcinoma cells (HepG2), umbilical vein endothelial cells (HUVEC), skeletal muscle 
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myoblasts (HSMM), normal lung fibroblasts (NHLF), normal epidermal keratinocytes 
(NHEK), and mammary epithelial cells (HMEC).
We used antibodies for histone H3 lysine 4 tri-methylation (H3K4me3), a modification 
associated with promoters4,5,9; H3K4me2, associated with promoters and enhancers1,3,6,9; 
H3K4me1, preferentially associated with enhancers1,6; lysine 9 acetylation (H3K9ac) and 
H3K27ac, associated with active regulatory regions9,10; H3K36me3 and H4K20me1, 
associated with transcribed regions3-5; H3K27me3, associated with Polycomb-repressed 
regions3,4; and CTCF, a sequence-specific insulator protein with diverse functions11. We 
validated each antibody by Western blots and peptide competitions, and sequenced input 
controls for each cell type. We also collected data for H3K9me3, RNAPII, and H2A.Z in a 
subset of cells.
This resulted in 90 chromatin maps corresponding to ~2.4 billion reads covering ~100 
billion bases across nine cell types, which we set out to interpret computationally.
Learning a common set of chromatin states across cell types
To summarize these datasets into nine readily interpretable annotations, one per cell type, 
we applied a multivariate Hidden Markov Model (HMM) that uses combinatorial patterns of 
chromatin marks to distinguish chromatin states8. The approach explicitly models mark 
combinations in a set of ‘emission’ parameters and spatial relationships between 
neighboring genomic segments in a set of ‘transition’ parameters (see Methods). It has the 
advantage of capturing regulatory elements with greater reliability, robustness and precision 
relative to studying individual marks8.
We learned chromatin states jointly by creating a virtual concatenation of all chromosomes 
from all cell types. We selected 15 states which showed distinct biological enrichments and 
were consistently recovered (Fig. 1a,b; Supplementary Fig. 1). Even though states were 
learned de novo based solely on the patterns of chromatin marks and their spatial 
relationships, they showed distinct associations with transcriptional start sites (TSSs), 
transcripts, evolutionarily-conserved non-coding regions, DNase hypersensitive sites12, 
binding sites for the regulators, c-Myc13 and NF-κB14, and inactive genomic regions 
associated with the nuclear lamina15 (Fig. 1c).
We distinguished six broad classes of chromatin states, which we refer to as promoter, 
enhancer, insulator, transcribed, repressed, and inactive states (Fig. 1c). Within them, active, 
weak and poised4 promoters (states 1-3) differ in expression levels, strong and weak 
candidate enhancers (states 4-7) differ in expression of proximal genes, and strongly and 
weakly transcribed regions (states 9-11) also differ in their positional enrichments along 
transcripts. Similarly, Polycomb-repressed regions (state 12) differ from heterochromatic 
and repetitive states (states 13-15), which are also enriched for H3K9me3 (Supplementary 
Fig. 2-4).
The states vary widely in their average segment length (~500bp for promoter and enhancer 
states vs. 10 kb for inactive regions), and in the portion of the genome covered (<1% for 
promoter and enhancer states vs. >70% for inactive state 13). For each state, coverage was 
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relatively stable across cell types (Supplementary Fig. 5), with the exception of ES cells in 
which the poised promoter state is more abundant while strong enhancer and Polycomb-
repressed states are depleted, consistent with the unique biology of pluripotent cells4,16.
We confirmed that promoter and enhancer states showed distinct biochemical properties 
(Supplementary Fig. 6). RNAPII was highly enriched at strong promoters, weakly enriched 
at strong enhancers, and nearly undetectable at weak/poised enhancers, consistent with 
strong transcription at promoters, and reports of weak transcription at active enhancers17,18. 
H2A.Z, a histone variant associated with nucleosome free regions19, was enriched in active 
promoters and strong enhancers, consistent with nucleosome displacement at TSSs and sites 
of abundant transcription factor (TF) binding in active enhancers.
We also used luciferase reporter assays to validate the functionality of predicted enhancers, 
the distinction between strong and weak enhancer states, and their predicted cell type-
specificity. We tested strong enhancers, weak enhancers, and strong enhancers specific to an 
unmatched cell type by transfection in HepG2 cells. We observed strong luciferase activity 
only for strong enhancer elements from the matched cell type (Fig. 1d).
These results and additional properties of the model (Supplementary Fig. 7-10) suggest that 
chromatin states are an inherent, biologically-informative feature of the genome. The 
framework enables us to reason about coordinated differences in marks by directly studying 
chromatin state changes between cell types (which we refer to as ‘changes’ or ‘dynamics’ 
without implying any temporal relationship).
Extent and significance of chromatin state changes across cell types
We next explored the extent to which chromatin states vary between pairs of cell types. The 
overall patterns of variability (Supplementary Fig. 11,12) suggest that regulatory regions 
vary dramatically in activity levels across cell types. Enhancer states show frequent 
interchange between strong and weak enhancers, and promoter states vary between active, 
weak and poised. Promoter states appear more stable than enhancers; they are eight times 
more likely to remain promoter states, controlling for coverage. Switching was also 
observed between promoter, enhancer, and transcriptional transition states, but no 
preferential changes were found to other groups. These general patterns suggest that despite 
varying activity levels, enhancer and promoter regions tend to preserve their chromatin 
identity as regions of regulatory potential.
Chromatin state differences between cell types relate to cell type-specific gene functions. An 
unbiased clustering of chromatin state profiles across annotated TSSs in lymphoblastoid and 
skeletal muscle cells distinguished informative patterns predictive of downstream gene 
expression and functional gene classes (Supplementary Fig. 13,14). Cell type-specific 
patterns were also evident when TSSs were simply assigned to the most prevalent chromatin 
state. Promoters activate in skeletal muscle were associated with extracellular structure 
genes (8.5-fold enrichment), those activate in lymphoblastoid cells with immune response 
genes (7.2-fold enrichment), and those active in both with metabolic housekeeping genes.
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Clustering of promoter and enhancer states based on their activity patterns
Extending our pair-wise promoter analysis, we clustered strong promoter and strong 
enhancer regions across all cell types (see Methods). This revealed clusters showing 
common activity and associated with highly coherent functions (Fig. 2a,b). For promoter 
clusters, these include immune response (GM12878-specific clusters, p<10−18), cholesterol 
transport (HepG2-specific, 10−4), and metabolic processes (all cells, 10−131). Remarkably, 
genes assigned to enhancer clusters by proximity also showed strong functional 
enrichments, including immune response (GM12878-specific, 10−6), lipid metabolism 
(HepG2-specific, 10−5) and angiogenesis (HUVEC-specific, 10−4).
Promoters and enhancers differed in their overall specificity. The majority of promoter 
clusters showed activity in multiple cell types, consistent with previous work5,10 (Fig. 2a). 
Enhancer clusters are significantly more cell type-specific, with few regions showing 
activity in more than two cell types and a majority being specific to a single cell type (Fig. 
2b).
We also found differences in the relative contributions of enhancer-based and promoter-
based regulation among gene classes. Developmental genes appear strongly regulated by 
both, showing the highest number of proximal enhancers and diverse promoter states, 
including poised and Polycomb-repressed (Supplementary Fig. 15). Tissue-specific genes 
(e.g. immune genes, steroid metabolism genes) appear more dependent on enhancer 
regulation, showing multiple tissue-specific enhancers but less diverse promoter states. 
Lastly, housekeeping genes are primarily promoter-regulated with few enhancers in their 
vicinity.
Overall, this dynamic view of the chromatin landscape suggests that multi-cell chromatin 
profiles can be as productive for systems biology as expression analysis has traditionally 
been, and may hold additional information on genome regulatory programs, which we 
explore next.
Correlations in activity profiles link enhancers to target genes
We next investigated functional interconnections between enhancers, the factors that 
activate or repress them, and the genes whose expression they regulate, by defining ‘activity 
profiles’ for each across the cell types (Fig. 3). We complemented these enhancer activity 
profiles (Fig. 3a) with profiles for gene expression (Fig. 3b), sequence motif enrichment 
(Fig. 3d), and the expression of TFs recognizing each motif (Fig. 3e). We used correlations 
between these profiles to probabilistically link enhancers to their downstream targets and 
upstream regulators (see Methods).
We found that patterns of enhancer activity (Fig. 2b,3a) correlated strongly with patterns of 
nearest-gene expression (Fig. 3b, correlation >0.9 in 16 of 20 clusters). Since this correlation 
remained high even for large distances (>50kb), we used activity correlation as a 
complement to genomic distance for linking enhancers to target genes (see Methods). 
Activity-based linking yielded increased functional gene class enrichments for several 
clusters (Supplementary Fig. 16).
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We validated our approach using quantitative trait locus (QTL) mapping studies which use 
co-variation between SNP alleles and gene expression levels to link cis-regulatory regions to 
target genes. Investigation of four recent QTL studies in liver20 and lymphoblastoid 
cells21-23 revealed remarkable agreement with our enhancer predictions. Enhancers linked to 
a given target gene by our method were significantly enriched for SNPs correlated with the 
gene’s expression level (Supplementary Fig. 17), thus confirming our enhancer-gene 
linkages with orthogonal data.
Correlations with TF expression and motif enrichment predict upstream regulators
We next predicted sequence-specific TFs likely to target enhancers in a given cluster based 
on regulatory motif enrichments. This implicated a number of TFs whose known biological 
roles matched the respective cell types (Fig. 3d, Supplementary Fig. 18). When ChIP-seq 
data was available in the relevant cell type, we confirmed that enriched motifs were 
preferentially bound by the cognate factor (Fig. 3c). Oct4 motif instances in cluster A (ES-
specific enhancers) were preferentially bound by Oct4 in ES cells24, and NF-kB motif 
instances in cluster F (lymphoblastoid-specific enhancers) were preferentially bound by NF-
kB in lymphoblastoid cells14. In both cases, motif instances in cell type-specific enhancers 
showed a ~5-fold increase in binding compared to other enhancers.
However, sequence-based motif enrichments do not distinguish causality. Enrichment could 
reflect a parallel binding event that does not affect the chromatin state, or the motif could 
actually be antagonistic to the enhancer state through specific repression in orthogonal cell 
types. To distinguish between these possibilities, we complemented the observed motif 
enrichments with cell type-specific expression for the corresponding TFs (Fig. 3e). We then 
correlated a ‘motif score’ based on motif enrichment in a given cluster, and a ‘TF-expression 
score’ based on the agreement between the TF expression pattern and the cluster activity 
profile (see Methods). A positive correlation between the two scores implies that the TF 
may be establishing or reinforcing the chromatin state. A negative correlation would instead 
imply that the TF may act as a repressor. For example, in addition to the enrichment of the 
Oct4 motif in the ES-specific cluster A, Oct4 is specifically expressed in ES cells, leading to 
its prediction as a causal regulator of ES cells (Fig. 3e), consistent with known biology16.
For 18 of the 20 clusters, this analysis revealed one or more candidate regulators. Recovery 
of known roles for well-studied regulators validated our approach. For example, HNF1, 
HNF4, and PPARγ are predicted as activators of HepG2-specific enhancers (clusters H,I), 
PU.1 and NF-κB as activators of lymphoblastoid (GM12878) enhancers (clusters C,F,G), 
Gata1 as an activator of K562-specific enhancers (cluster B) and Myf as an activator of 
skeletal muscle (HSMM) enhancers (cluster O)14,25-27.
The analysis also revealed potentially novel regulatory interactions. ETS factors 
(Elk1,Tel2,Ets) are predicted activators of enhancers active in both GM12878 and HUVEC 
(cluster G), but not of GM12878-specific or HUVEC-specific clusters emphasizing the 
value of unbiased clustering. These connections are consistent with reported roles for ETS 
factors in lymphopoiesis and endothelium28. The prediction of p53 as an activator in 
HSMM, NHLF, NHEK and HMEC (clusters N,Q,R) likely reflects its maintained activity in 
these primary cells as opposed to other cell models where it may be suppressed by mutation 
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(K562)29, viral inactivation (GM12878)30 or cytoplasmic localization (ES cells)31. A 
widespread role for p53 in regulating distal elements is consistent with its known binding to 
distal regions32,33.
Our analysis also revealed several repressor signatures, including Gfi1 in K562 and 
GM12878 cells (clusters B,C) and Bach2 in ES cells (cluster A). Both regulators are known 
to repress transcription by recruiting histone deacetylases and methyltransferases to 
proximal promoters34,35, and Gfi1 has also been implicated in silencing of satellite 
repeats35. Our regulatory inferences suggest that they also modulate chromatin to inhibit 
enhancer activity, thus proposing a new mechanism for distal gene regulation.
Validation of predicted binding events and regulatory outcomes
The regulatory inferences above imply TF binding events at motif instances within enhancer 
regions in specific cellular contexts, which we sought to validate using a general molecular 
signature. Binding events are associated with nucleosome displacement, a structural change 
evident in ChIP-seq data for histones36. We thus studied local depletions in the chromatin 
intensity profiles (‘dips’) as indicative of TF binding. We confirmed that dips were present 
in individual signal tracks at active enhancers, and were associated with preferential 
sequence conservation and regulatory motif instances (Fig. 4a).
To test our specific predictions, we superimposed chromatin profiles of coordinately 
regulated enhancer regions, anchoring them on the implied motif instances. Striking dips 
precisely coincide with regulatory motifs, and are both cell type-specific and region-specific, 
exactly as predicted (Fig. 4b,c). As dips only appear when the factor is expressed, they also 
support the identity of the trans-acting TF.
To validate that predicted causal motifs contribute to enhancer activity, we used luciferase 
reporters. Our model implicated HNF regulators as activators of HepG2-specific enhancers 
(Fig. 3), and context-specific dips supported binding interactions (Fig. 4c). We thus selected 
for functional analysis 10 sites with HNF motifs showing dips in strong HepG2-specific 
enhancers, and evaluated them with and without the HNF motif. We found that permutation 
of the motif consistently led to a reduction in enhancer activity (Fig. 4d), supporting its 
predicted causal role.
Assigning candidate regulatory functions to disease-associated variants
Finally, we explored whether our chromatin annotations and regulatory predictions can 
provide insight into sequence variants associated with disease phenotypes. To that effect, we 
gathered a large set of non-coding SNPs from GWAS catalogs, an exceedingly small 
proportion of which are currently understood37.
We found that disease-associated SNPs are significantly more likely to coincide with strong 
enhancers (states 4,5; 2-fold enrichment, p<10−10), despite the fact that no notable 
association to these states are seen for SNPs in general or for those SNPs tested in the 
studies. To test whether SNPs associated with a particular disease might have even more 
specific correspondences, we examined 426 GWAS datasets. We identified 10 studies38-47 
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whose variants showed significant correspondences to cell type-specific strong enhancer 
states (see Methods; Fig. 5a).
Individual variants from these studies were strongly enriched in enhancer states specifically 
active in relevant cell types (Fig. 5a,b). For example, SNPs associated with erythrocyte 
phenotypes38 were found in erythroleukemia cell (K562) enhancers, SNPs associated with 
systemic lupus erythematosus39 were found in lymphoblastoid cell (GM12878) enhancers, 
while SNPs associated with triglyceride40 phenotypes or blood lipid phenotypes41 were 
found in hepatocellular carcinoma cell (HepG2) enhancers. We also applied our model to 
chromatin data for T-cells3 (Supplementary Fig. 19), for which strong enhancer states 
correlated to variants associated with risk of childhood acute lymphoblastic leukemia48, 
further validating our approach.
We also used our predicted enhancer-target gene associations to find candidate downstream 
genes whose expression might be affected by cis-changes occurring in the enhancer region. 
Although most of the predicted target genes are proximal to the enhancer, a subset of more 
distal predicted targets could reflect novel candidates for the disease phenotypes (Fig. 5b).
In addition, we identified several instances where a lead GWAS variant does not correspond 
to a particular chromatin element but a linked variant coincides with an enhancer with the 
predicted cell type-specificity (Fig. 5c). Thus, chromatin profiles may provide a general 
means to triage variants within a haplotype block, a common problem faced in GWAS.
Lastly, we identified several cases in which a disease-associated SNP created or disrupted a 
regulatory motif instance for a predicted causal TF in the relevant cell type (Fig. 5d), 
suggesting a specific molecular mechanism by which the disease-associated genotype could 
lead to the observed disease phenotype consistent with our regulatory predictions.
Discussion
Our work provides a systematic view of many chromatin marks across many cell types, 
demonstrating the power of chromatin profiling as an additional and dynamic layer of 
genome annotation. We presented methods to distinguish different classes of functional 
elements, elucidate their cell type-specificities, and reveal cis-regulatory interactions that 
govern them and ultimately drive target gene expression. By intersecting our predictions 
with non-coding SNPs from GWAS datasets, we propose potential mechanistic explanations 
for disease variants, either through their presence within cell type-specific enhancer states, 
or by their effect on binding motifs for predicted regulators.
Chromatin states dramatically reduced the large combinatorial space of 90 chromatin 
datasets (2^90 combinations) into a manageable set of biologically-interpretable annotations, 
thus providing an efficient and robust way to track coordinated changes across cell types. 
This enabled the systematic identification and comparison of >100 thousand promoter and 
enhancer elements. Both types of elements are cell type-specific, associated with motif 
enrichments, and assume strong, weak and poised states that correlate with neighboring gene 
expression and function. Enhancers showed exquisite tissue-specificity, enrichment in the 
vicinity of developmental and cell type-specific genes, and predictive power for proximal 
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gene expression, reinforcing their roles as sentinels of tissue-specific gene expression49. By 
elucidating enhancers systematically, and linking them to upstream regulators and 
downstream genes, our analysis can help provide a missing link between regulators and 
target genes. The power of the approach should increase considerably as additional 
phenotypically-distinct cell types are surveyed, and enable a greater proportion of enhancer 
elements to be incorporated into the connectivity network.
The inferred cis-regulatory interactions make specific testable predictions, many of which 
were confirmed through additional experiments and analyses. Our enhancer-target gene 
linkages are supported by cis-regulatory inferences from QTL mapping studies. Predicted 
TF-motif interactions within cell type-specific enhancers were confirmed in specific cases 
by TF binding and more generally by depletions in the chromatin profiles at causal motifs in 
appropriate cellular contexts. Motifs predicted as causal regulators of cell type-specific 
enhancers were also confirmed in enhancer assays.
The regulatory inferences afforded by multi-cell chromatin profiles are unique and highly 
complementary to datasets for TF binding, expression, chromatin accessibility, nucleosome 
positioning, and chromosome conformation50. For example, our regulatory predictions can 
help focus the spectrum of TF binding events to a smaller number of functional interactions. 
The chromatin-centric approach also complements the extensive body of work on biological 
network inference from expression data with the potential to introduce enhancers and other 
genomic elements into connectivity networks.
Our study has important implications for the understanding of disease. Our detailed and 
dynamic functional annotations of the relatively uncharted non-coding genome can facilitate 
the interpretation of GWAS datasets by predicting specific cell types and regulators related 
to specific diseases and phenotypes. Furthermore, the connections derived for enhancer 
regions, to upstream regulators and downstream genes, propose cis- and trans-acting 
interactions that may be modulated by the sequence variants. While the current study 
represents only a first small step in this direction, we expect that future iterations with 
greater diversity of cell types and improved methodologies will help define the molecular 
underpinnings of human disease.
Methods Summary
ChIP-seq analysis was performed in biological replicate as described4 using antibodies 
validated by Western blots and peptide competitions. ChIP DNA and input controls were 
sequenced using the Illumina Genome Analyzer. Expression profiles were acquired using 
Affymetrix GeneChip arrays. Chromatin states were learned jointly by applying an HMM8 
to 10 data tracks for each of the 9 cell types. We focused on a 15 state model that provides 
sufficient resolution to resolve biologically-meaningful patterns yet is reproducible across 
cell types when independently processed. We used this model to produce 9 genome-wide 
chromatin state annotations, which were validated by additional ChIP experiments and 
reporter assays. Multi-cell type clustering was conducted on locations assigned to strong 
promoter state 1 (or strong enhancer state 4) in at least one cell type using the k-means 
algorithm. Enhancer-target gene linkages were predicted by correlating normalized signal 
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intensities of H3K27ac, H3K4me1 and H3K4me2 with gene expression across cell types as 
a function of distance to the TSS. Upstream regulators were predicted using a set of known 
TF motifs assembled from multiple sources. Motif instances were identified by sequence 
match and evolutionary conservation. P-values for GWAS studies were based on 
randomizing the location of SNPs, and the FDR based on randomizing the assignment of 
SNPs across studies. Datasets are available from the ENCODE website (http://
genome.ucsc.edu/ENCODE), the supporting website for this paper (http://compbio.mit.edu/
ENCODE_chromatin_states), and the Gene Expression Omnibus (GSE26386).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Appendix
Methods
Cell culture
Human H1 ES cells were cultured in TeSR media51 on Matrigel by Cellular Dynamics 
International. Cells were split with dispase and harvested at a passage number between 30 
and 40. Prior to harvest, cells were karyotyped and stained for Oct4 to confirm pluripotency. 
K562 erythrocytic leukemia cells (ATCC CCL-243, lot # 4607240) were grown in 
suspension in RPMI medium (HyClone SH30022.02) with 10% fetal bovine serum (FBS) 
and 1% Antibiotic - Antimycotic (GIBCO 15240-062). Cell density was maintained between 
3 × 105 and 7 × 105 cells/ml. GM12878 B-lymphoblastoid cells (Coriell Cell Repositories, 
“expansion A”) were grown in suspension in RPMI 1640 medium with 15% FBS (not heat 
inactivated), 2 mM L-glutamine and 1% penicillin/streptomycin. Cells were seeded at a 
concentration of ~2 × 105 viable cells/ml with minimal disruption, and maintained between 
3 × 105 and 7 × 105 cells/ml. HepG2 hepatocellular carcinoma cells (ATCC HB-8065, lot# 
4968519) were cultured in DMEM (HyClone SH30022.02) with 10% FBS and 1% 
penicillin/streptomycin. Cells were trypsinized, resuspended to single cell suspension, split 
to a confluence between 15 and 20% and then harvested at ~75% confluence. NHEK 
normal human epidermal keratinocytes isolated from skin (Lonza CC-2501, lot# 4F1155J, 
passage 1) were grown in keratinocyte basal medium 2 (KGM-2 BulletKit, Lonza) 
supplemented with BPE, hEGF, hydrocortisone, GA-1000, transferrin, epinephrine and 
insulin. Cells were seeded at recommended density (3500 cells/cm2), subjected to two to 
three passages on polystyrene tissue culture plates and harvested at a confluence of 70 to 
80%. HSMM primary human skeletal muscle myoblasts (Lonza CC-2580, lot#6F4444, 
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passage 2) were cultured in Smooth Muscle Growth Medium-2 (SkGM-2 BulletKit, Lonza) 
supplemented with rhEGF, dexamethasone, L-glutamine, FBS, and GA-1000. Cells were 
seeded at recommended density (3500 cells/cm2), subjected to two to three passages, and 
harvested at a confluence of 50 to 70%. NHLF primary normal human lung fibroblasts 
(Lonza CC-2512, lot#4F0758, passage 2) were grown in Fibroblast Cell Basal Medium 2 
(FGM-2 BulletKit, Lonza) supplemented with hFGF-β, insulin, FBS and GA-100. Cells 
were seeded at recommended density (2500 cells/cm2), subjected to two to three passages, 
and harvested at an approximate confluence of 80%. HUVEC primary human umbilical 
vein endothelial cells (Lonza CC-2517, lot# 7F3239, passage 1) were grown in endothelial 
basal medium 2 (EGM-2 BulletKit, Lonza) supplemented with hFGF-β, hydrocortisone, 
VEGF, R3-IGF-1, ascorbic acid, heparin, FBS, hEGF and GA-1000. Cells were seeded at 
recommended density (2500 – 5000 cells/cm2), subjected to two to three passages, and 
harvested at a confluence of 70 to 80%. HMEC primary human mammary epithelial cells 
from mammary reduction tissue (Lonza CC-2551, passage 7) were grown in mammary 
epithelia basal medium (MEGM BulletKit, Lonza) supplemented with hEGF-β, 
hydrocortisone, BPE, GA-1000 and insulin. Cells were seeded as recommended density 
(2500 cells/cm2), subjected two to three passages and harvested at 60 to 80% confluence.
Antibodies
ChIP assays were performed using the following antibody reagents: H3K4me1 (Abcam 
ab8895, lot 38311/659352), H3K4me2 (Abcam ab7766, lot 56293), H3K4me3 (Abcam 
ab8580, lot 331024; Milipore 04-473, lot DAM1623866), H3K9ac (Abcam ab44441, lot 
455103/550799), H3K27ac (Abcam ab4729, lot 31456), H3K36me3 (Abcam ab9050, lot 
136353), H4K20me1 (Abcam ab9051, lot 104513/519198), H3K27me3 (Millipore 07-449, 
lot DAM1387952/DAM1514011), CTCF (Millipore 07-729, lot 1350637), H3K9me3 
(Abcam ab8898, lot 484088), H2A.Z (Millipore 07-594, lot DAM1504736) and RNAPII N-
terminus (Santa Cruz sc-899X, lot H0510). All antibody lots were extensively validated for 
specificity and efficacy in ChIP-seq. Western blots were used to confirm specific 
recognition of histone protein (or CTCF). Dot plots performed using arrayed histone tail 
peptides representing various modification states were used to confirm specificity for the 
appropriate modification. ChIP-seq assays performed on a common cell reagent were used 
to confirm consistency between different lots of the same antibody.
Chromatin immunoprecipitation (ChIP)
Cells were harvested by cross-linking with 1% formaldehyde in cell culture medium for 10 
min at 37 °C. After quenching with the addition of 125 mM glycine for 5 min at 37 °C, the 
cells were washed twice with cold PBS containing protease inhibitor (Roche). After 
aspiration of all liquid, pellets consisting of ~107 cells were flash frozen and stored at 
−80°C. Fixed cells were thawed and sonicated to obtain chromatin fragments of ~200 to 700 
bp using a Bioruptor (Diagenode). Immunoprecipitations were performed as described, 
retaining a fraction of input ‘whole cell extract’ (WCE) as a control4. Briefly, sonicated 
chromatin was diluted 10-fold and incubated with ~5 μg antibody overnight. Antibody–
chromatin complexes were pulled-down using protein A-sepharose, washed and then eluted. 
After cross-link reversal and proteinase K treatment, immunoprecipitated DNA was 
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extracted with phenol, precipitated in ethanol, and treated with RNase. ChIP DNA was 
quantified by fluorometry using the Qubit assay (Invitrogen).
Next-generation sequencing
For each ChIP or control sample, ~5 ng of DNA was used to generate a standard Illumina 
sequencing library. Briefly, DNA fragments were end-repaired using the End-It DNA End-
Repair Kit (Epicentre), extended with a 3′ ‘A’ base using Klenow (3′→5′ exo-, 0.3 U/μl, 
NEB), ligated to standard Illumina adapters (75 bp with a ‘T’ overhang) using DNA ligase 
(0.05 U/μl, NEB), gel purified on 2% agarose, retaining products between 275 and 700 bp, 
and subjected to 18 PCR cycles. These libraries were quantified by fluorometry and 
evaluated by quantitative PCR or a multiplexed digital hybridization-based analysis 
(NanoString nCounter)52 to confirm representation and specific enrichment of DNA species. 
Libraries were sequenced in one or two lanes on the Illumina Genome Analyzer using 
standard procedures for cluster amplification and sequencing-by-synthesis.
Expression profiling
Cytosolic RNA was isolated using RNeasy Columns (Qiagen) from the same cell lots as 
above. Gene expression profiles were acquired using Affymetrix GeneChip arrays. The data 
were normalized using the GenePattern expression data analysis package53. CEL files were 
processed by RMA, quantile normalization and background correction. Two replicate 
expression datasets for each cell type were averaged and log2 transformed. Gene level 
normalization across cell types was computed by mean normalization.
Primary processing of sequencing reads
ChIP-seq reads were aligned to human genome build HG18 with Maq (http://
maq.sourceforge.net/maqman.shtml) using default parameters. All reads were truncated to 
36 bases before alignment. Signal density maps for visualization were derived by extending 
sequencing reads by 200 bp in the 3′ direction (the estimated median size of ChIP 
fragments), and then counting the total number of overlapping reads at 25 bp intervals. 
Replicate ChIP-seq experiments were verified by comparing enriched intervals as 
described4, and then combined into a single dataset. For the HMM, density maps were 
derived by extending sequencing reads by 200 bp in the 3′ direction and then assigning them 
to a single 200 bp window based on the midpoint of the extended read. These maps were 
then binarized at a 200 bp resolution based on a Poisson background model using a 
threshold of 10−4.
Joint learning of HMM states across cell types
To handle data from the 9 cell types, we concatenated their genomes to create an extended 
virtual genome that we used to train the HMM. We applied the model to ten tracks 
corresponding to the different chromatin marks and input using a multivariate HMM-model 
as described8. Here, we used a Euclidean distance for determining initial parameters for the 
nested initialization step. After learning and evaluating a set of roughly nested models, 
considering up to 25 states, we focused on a 15 state model that provides sufficient 
resolution to resolve biologically-meaningful chromatin patterns and yet is highly 
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reproducible across cell types when independently processed (Supplementary Fig. 7). We 
used this model to compute the probability that each location is in a given state, and then 
assigned each 200 bp interval to its most likely state for each cell type. Even though our 
model focuses on presence/absence frequencies of marks, we found that our states also 
capture signal intensity differences between high-frequency and low-frequency marks 
(Supplementary Fig. 9).
Enrichment analysis
For each state, enrichments for different annotations were computed at 200 bp resolution, 
with the exception of conservation which was computed at nucleotide resolution. We used 
annotations obtained through the UCSC Genome Browser54 for RefSeq TSSs and 
transcribed regions55, PhastCons56, DNase-seq for K562 cells12, c-Myc ChIP-seq for K562 
cells13, NF-κB ChIP-seq for GM1287814, Oct4 in ES cells24 and nuclear lamina15. Gene 
functional group enrichments were determined using STEM57 and biological process 
annotations in the Gene Ontology database58. P-values were calculated based on 
hypergeometric distribution and corrected for multiple testing using Bonferonni correction.
Comparing chromatin state assignments between cell types
For each pair of cell types, the chromatin state assignments at each genomic position were 
compared. We calculated the frequency with which each pair of states occurred, and 
normalized this against the expected frequency based on the amount of genome covered by 
each state. The fold-enrichments in Figure 2a reflect an aggregation across all 72 possible 
pairs of cell types.
Pair-wise promoter clustering
Promoters for RefSeq genes were clustered based on the most likely chromatin state 
assignment across a 2 kb region centered on the TSS. Clustering was performed jointly 
across GM12878 and HSMM, and was restricted to genes with corresponding Affymetrix 
expression. Briefly, each promoter was treated as a 330 element binary vector where each 
position of the vector corresponded to a position along the promoter, cell type and state. 
Clustering was performed on these vectors by k-means in Matlab. Gene expression values 
were calculated based on the corresponding Affymetrix probe set closest to the TSS.
Multi-cell type promoter and enhancer clustering
Promoter state clustering was performed for all 200 bp intervals assigned to the strong 
promoter state (state 1) in at least one cell type. Each interval was represented by a single 
vector corresponding to the estimated probabilities that it is in the strong promoter state for 
each of the 9 cell types, accounting for model assignment uncertainty and biological noise. 
These were determined from the model posterior probabilities of state assignments and a 
comparison of state assignments in replicate experimental data. Clustering was performed 
by k-means using Matlab. We found that 20 clusters provided sufficient resolution to 
distinguish major cell type-specific patterns. Enhancer state clustering was performed for all 
200 bp intervals assigned to strong enhancer state 4 in at least one cell type using identical 
procedures. For the purposes of display in Figure 2, the locations were randomly down-
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sampled. For the purpose of identifying enriched functional gene categories in Figure 2b, 
enhancers were linked to the nearest TSS up to 50 kb distant excluding those within 5kb. 
Enhancer-gene correspondences based on the nearest gene were used for the expression 
analysis of distance based linked genes in Figure 3b.
Linking enhancer locations to correlated genes
To predict linkages between enhancer states and target genes, we combined distance-based 
information with correlation across cell types of gene expression levels with read-depth 
normalized signal intensity of three histone modifications associated with enhancer states: 
H3K4me1, H3K4me2 and H3K27ac. For each enhancer state (4-7), cell type, and 200bp 
interval between 5kb and 125kb from the TSS, we trained logistic regression classifiers. The 
classifiers were trained to use mark intensity-expression correlation values to distinguish 
real instances of pairs of enhancer states and gene expression values from control pairs 
based on randomly re-assigning expression values to different genes. To learn a smooth and 
robust function at each position we included as part of the training all enhancer state 
assignments within a 10kb window centered at the position. The link score for a specific 
enhancer-gene linkage was defined as the ratio of the corresponding logistic regression 
classifier probability score to that for the randomized data.
For the evaluation of the expression quantitative trait loci (QTL) analysis we used a link 
score of 2.5. The eQTL data was obtained from the University of Chicago QTL browser 
(http://eqtl.uchicago.edu/cgibin/gbrowse/eqtl/). In the QTL evaluation for each SNP that 
overlapped a strong enhancer state (4 or 5) and was within 125kb of a TSS excluding 
locations within 5kb and was associated with a gene for which we had expression data was 
considered eligible to be supported by our linked predictions. We computed the fraction we 
observed linked based on our linked predictions relative to the fraction that would be 
expected to be linked conditioned on knowing the distance distributions of the SNPs relative 
to the gene TSS.
For the evaluation of linked predictions using the Gene Ontology we use the same link score 
and the same distance relative to the TSS used to define genes associated with clusters. The 
base set of genes in the enrichment analysis here were all genes which could be linked in at 
least one cluster.
Motif and TF analysis
A database of known TF motifs was collated by combining motifs from TRANSFAC 
(version 11.3)59, Jaspar (2010-05-07)60 and protein binding microarray datasets61-63. Motif 
instances in non-coding and non-repetitive regions of the genome were identified using 
these motifs and sequence conservation using a 29-way alignment of Eutherian mammal 
genomes (Lindblad-Toh et al, in preparation). These were filtered using a significance 
threshold of p<4−8 for the motifs64, and confidence level based on conservation. Motifs 
were linked to corresponding TFs using metadata provided by the source. Motif enrichments 
for chromatin state clusters were computed as ratios to the instances of shuffled motifs, in 
order to correct for non-specific conservation and composition. A confidence interval was 
calculated for each ratio using Wilson score intervals (z=1.5), selecting the most 
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conservative value within the confidence interval. In cases where multiple motif variants 
were available for the same TF, the one that showed the most variance in enrichment across 
clusters was selected.
For predicting causal activators and repressors, motif scores and TF expression scores were 
correlated as follows. Motif scores were calculated as described above. TF expression scores 
were calculated for each cluster by correlating the expression of the TF across the cell types 
with the activity profile of the enhancers in that cluster (defined by the cluster means from 
the k-means clustering). The motif scores and the TF expression scores were then correlated 
against each other to identify positively- and negatively-correlated TFs.
TF-motif interactions predicted for strong enhancer states in specific cell types were 
validated by using the raw ChIP-seq tag enrichments as proxy for nucleosome positioning. 
For this purpose, sequencing reads were processed as above, except that the middle 75 bp of 
inferred ChIP fragments were used to derive signal density informative of nucleosome-
depletion (dips), as described36. Superposition plots show tag enrichments relative to a 
uniform background computed based on sequencing depth.
Quantitative real-time PCR
Enrichment ratios for RNAPII and H2A.Z ChIPs were determined relative to input 
chromatin by quantitative real-time PCR using an ABI 7900 detection system, in biological 
replicate as described previously65. Regions used for validation correspond to 3 different 
chromatin states, including 13 for state 1 (arbitrarily selected), 11 for state 4 (arbitrarily 
selected but excluding regions within 2 kb of a state 1 annotation) and 11 for state 7 
(arbitrarily selected but excluding regions within 2 kb of a state 1 or state 4 annotation). 
PCR primers are listed in Supplementary Data 1.
Functional enhancer assays
The SV40 promoter was first inserted between the HindIII and NcoI sites of pGL4.10 
(Promega). Next, 250bp sequences from the reference genome (hg18) corresponding to 
different chromatin states (8 from HepG2 state 4, 7 from HepG2 state 7, and 7 from 
GM12878 state 4) were synthesized (GenScript) and then inserted between the two SfiI sites 
upstream of the SV40 promoter. HepG2 cells were seeded into 96 well plates at a density of 
5×10^4 cells/well and expanded overnight to ~50% confluency. The cells were then 
transfected with 400 ng of a pGL4.10-derived plasmid and 100 ng of pGL4.73 (Promega) 
using Lipofectamine LTX. Firefly and Renilla luciferase activities were measured 24 hr post 
transfection using Dual-Glow (Promega) and an EnVision 2103 multilabel reader 
(PerkinElmer) from triplicate experiments. Data are reported as light units relative to a 
control plasmid. For validation of causal TF motifs, 10 sequences of 250 bp corresponding 
to HepG2-specific strong enhancers (state 4) with dips and HNF motifs were tested as 
above, and compared to identical sequences except with the HNF motif permuted. Tested 
enhancer elements are listed in Supplementary Data 1.
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GWAS SNP Analysis
The GWAS variants and SNP coordinates were obtained from the NHGRI catalog and the 
UCSC browser (October 30, 2010)37,54. This set was refined by extending the blood lipid 
GWAS41 set to contain all reported SNPs, and by bifurcating the hematological and 
biochemical traits study46 into a hematological traits set and a biochemical traits set. We 
limited our analysis to studies reporting 2 or more associated SNPs. The variants from each 
study were intersected with chromatin states from each of the cell types. The reported p-
values were based on the overlap of associated SNPs with strong enhancer states 4 and 5. 
We controlled for non-independence between proximal SNPs based on a randomization test 
where SNPs were randomly shifted while preserving relative distance. We then defined an 
estimated false discovery rate based on permutations in which SNPs were randomly re-
assigned to different studies, and recomputed corrected p-values. Estimates of false 
discovery rates based on these permutations control for multiple testing of studies and cell 
types and for general non-specific enrichments for states 4 and 5 with GWAS hits. 
Candidate gene targets were predicted for a subset of variants associated with enhancer 
states based on the lead cell type using the linking method described above.
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Figure 1. Chromatin state discovery and characterization
a, Top: Profiles for nine chromatin marks (grayscale) are shown across the wntless (WLS) 
gene in four cell types, and summarized in a single chromatin state annotation track for each 
(colored according to b). WLS is poised in ES cells, repressed in GM12878 cells, and 
transcribed in HUVEC and NHLF. Its TSS switches accordingly between poised (purple), 
repressed (grey) and active (red) promoter states; enhancer regions within the gene body 
become strongly activated (orange, yellow); and its gene body changes from low signal 
(white) to transcribed (green). These chromatin state changes summarize coordinated 
changes in many chromatin marks; for example, H3K27me3, H3K4me3 and H3K4me2 
jointly mark a poised promoter, while loss of H3K27me3 and gain of H3K27ac and H3K9ac 
mark promoter activation. Bottom: Nine chromatin state tracks, one per cell type, in a 900kb 
region centered at WLS summarize 90 chromatin tracks in directly-interpretable dynamic 
annotations, showing activation and repression patterns for 6 genes and hundreds of 
regulatory regions, including enhancer states. b, Chromatin states learned jointly across cell 
types by a multivariate HMM. Table shows emission parameters learned de novo based on 
genome-wide recurrent combinations of chromatin marks. Each entry denotes the frequency 
with which a given mark is found at genomic positions corresponding to the chromatin state. 
c, Genome coverage, functional enrichments, and candidate annotations for each chromatin 
state. Blue shading indicates intensity, scaled by column. d, Box plot depicts enhancer 
activity for predicted regulatory elements. 250bp-long sequences corresponding to strong or 
weak/poised HepG2 enhancer elements, or GM12878-specific strong enhancer elements 
were inserted upstream of a luciferase gene and transfected into HepG2 cells. Reporter 
activity was measured in relative light units. Robust activity is seen for strong enhancers in 
the matched cell type, but not for weak/poised enhancers or for strong enhancers specific to 
a different cell type. Box-and-whiskers indicate 5th, 25th, 50th, 75th and 95th percentiles.
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Figure 2. Cell type-specific promoter and enhancer states and associated functional enrichments
a, Clustering of genomic locations (rows) assigned to active promoter state 1 (red) across 
cell types (columns) reveals 20 common patterns of activity (A-T) (see Methods). For each 
cluster, enriched gene ontology (GO) terms are shown with hypergeometric P-value and 
fold-enrichment, based on nearest TSS. For most clusters, several cell types show strong 
(dark red) or moderate (light red) activity. b, Analogous clustering and functional 
enrichments for strong enhancer state 4 (yellow). Enhancer states show greater cell type-
specificity, with most clusters active in only one cell type.
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Figure 3. Correlations in activity patterns link enhancers to gene targets and upstream 
regulators
a, Average enhancer activity across the cell types (columns) for each enhancer cluster 
(rows) defined in Figure 2b (labeled A-T) and number of 200bp windows in each cluster. b, 
Average mRNA expression of nearest gene across the cell types and correlation with 
enhancer activity profile from a. High correlations between enhancer activity and gene 
expression provide a means for linking enhancers to target genes. c, Enrichment for Oct4 
binding in ES cells24 and NF-κB binding in lymphoblastoid cells14 for each cluster. d, 
Strongly enriched (red) or depleted (blue) motifs for each cluster, from a catalog of 323 
consensus motifs. e, Predicted causal regulators for each cluster based on positive 
(activators) or negative (repressors) correlations between motif enrichment (top left 
triangles) and TF expression (bottom right triangles). For example, a red/yellow 
combination predicts Oct4 as a positive regulator of ES-specific enhancers, as its motif-
based predicted targets are enriched (red upper triangle) for enhancers active in ES (cluster 
A), and the Oct4 gene is expressed specifically in ES cells, resulting in a positive TF 
expression correlation (yellow triangle). Overall correlations between motif and TF 
expression across all clusters denote predicted activators (positive correlation, orange) and 
repressors (negative correlation, purple).
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Figure 4. Validation of regulatory predictions by nucleosome depletions and enhancer activity
a, Dips in chromatin intensity profiles in a K562-specific strong enhancer (orange) coincide 
with a predicted causal GATA motif instance (logo). The dips likely reflect nucleosome 
displacement associated with TF binding, supported by DNase hypersensitivity12 and 
GATA1 binding25. b, Superposition of H3K27ac signal across loci containing GATA 
motifs, centered on motif instances, shows dips in K562 cells, as predicted. c, Superposition 
of H3K4me2 signal for HepG2 cells shows dips over HNF4 motifs in strong enhancer states, 
as predicted. d, HepG2-specific strong enhancers with predicted causal HNF motifs were 
tested in reporter assays. Constructs with permuted HNF motifs (red) led to significantly 
reduced luciferase activity compared to wild type (blue), with an average 2-fold reduction. 
Mean luciferase relative light units over three replicates and 95% confidence intervals are 
indicated.
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Figure 5. Disease variants annotated by chromatin dynamics and regulatory predictions
a, Intersection of strong enhancer states (4,5) with disease-associated SNPs from GWAS 
studies shows significant enrichment (blue shading) in relevant cell types (see Methods). 
Fold-enrichments of the SNPs in strong enhancer states for each cell type are indicated. b, 
For three GWAS datasets38-40, state annotations are shown for a subset of lead SNPs in the 
9 cell types (colors as in Figure 1b, except state 11 is white). Strong enhancer state (orange) 
is most prevalent in cell types related to the phenotype. For SNPs overlapping strong 
enhancers, proximal genes with correlated expression are indicated, with linking score and 
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distance. c, Example GWAS locus with blood lipid traits41 association, where the lead 
variant (red circle) has no functional annotation but a linked SNP (arrow) coincides with a 
HepG2-specific strong enhancer (orange), and may represent a causal variant. Strong 
enhancer annotations are shown for all cell types. d, Example GWAS loci where disease 
SNP affects a conserved instance of a predicted causal motif. Left: Lead SNP rs9374080 in 
the erythrocyte phenotype GWAS38 is <100 bp from a strong enhancer in K562 
erythroleukemia cells and strengthens a motif for Gfi1b, a predicted repressor in K562 (Fig. 
3d). Right: SNP rs9271055 associated with lupus39 coincides with a lymphoblastoid 
(GM12878)-specific strong enhancer and strengthens a motif for Ets1, a predicted activator 
of lymphoblastoid enhancers (Fig. 3d). This factor is further implicated by lupus-associated 
variants that directly affect the Ets1 locus39.
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